Gram-Negative Bacterial Infection Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2022 - 2032

  • Single User License $3500

Gram-Negative Bacterial Infection Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2022 - 2032

Status : October, 2022 | Healthcare IT

Report Digest


Gram-Negative Bacterial Infection Market: Overview

Antimicrobial resistance has been a soaring concern for a variety of diseases, especially for respiratory tract infections, enteric fever, and some other infections that are related to GNB (gram-negative bacilli). The factor is likely to serve as a vital factor to propel revenue generation opportunities in the gram-negative bacterial infection market.

In addition to this, surging antibiotic resistance has been primarily owing to inappropriate and indiscriminate use of antibiotics. Furthermore, there has been a noteworthy decline in the development of effectiveness of antimicrobial agents.

The burden is more critical and alarming in the case of infections that are caused by MDR (multidrug-resistance) gram-negative bacteria. So, there arises a crucial requirement to provide effective healthcare solutions against these infections. These factors are likely to work as revenue generators in the gram-negative bacterial infection market in the near future.

Gram-Negative Bacterial Infection Market: Key Trends

There are a few MDR gram-negative bacterial organisms that are likely to pose threats. Some of these organisms include Neisseria gonorrhoeae, Pseudomonas aeruginosa, Helicobacter pylori, Acinetobacter baumannii, Helicobacter pylori, Enterobacteriaceae, and Enterococcus faecium. Most of these organisms are related to cause urinary tract infections, pneumonia, and nosocomial infections. The increasing burden of these infections on the health of the global population, especially in the developing countries is owing to the rate of the growing antibiotic resistance compared to the speed of the development of novel drugs. So, it becomes mandatory for the companies serving in the pharmaceutical industry and drug makers to concentrate on the expansion of novel therapeutics. Furthermore, these initiatives are estimated to accelerate the count of research activities and thus fuel expansion opportunities in the gram-negative bacterial infection market.

The emergence as well as the proliferation of the highly resistant bacteria has been serving as a noteworthy concern due to the availability of the limited count of antimicrobial agents that are accessible to combat these issues of organisms. Further, the inappropriate use of antibiotics has been predicted to contribute to the emergence of various organisms and thus create the requirement for effective and reliable therapeutics to treat the infection. Thus, the number of R & D activities and rising investments are predicted to drive growth opportunities in the gram-negative bacterial infection market.

Gram-Negative Bacterial Infection Market: Competitive Dynamics and Key Developments

The players serving in the gram-negative bacterial infection market have been primarily concentrating to develop more effective drugs. Further, these players are also adopting different strategies for the generation of novel growth opportunities. Acquisitions & mergers, collaborations, agreements, partnerships, portfolio expansion, and many other strategies are incorporated by industry players.

For instance, Prokarium Ltd. developed Typhetec in order to treat gram-negative bacterial infections. Presently, the drug has been under the clinical trial from phase II. Further, based on the result of phase I, the drug is beneficial to treat the infections and thus contributes to market growth opportunities.

The key players operating in the gram-negative bacterial infection market are:

  • Baxter International Inc.
  • Rib-X Pharmaceuticals, Inc.
  • Sanofi-Aventis
  • GlaxoSmithKline Plc.
  • Nektar Therapeutics
  • Takeda Pharmaceutical Company Limited
  • Dainippon Sumitomo Pharma Co., Ltd.
  • Targeted Genetics Corporation.
  • Novartis AG, Pfizer Inc.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

Frequently Asked Questions

Antimicrobial resistance is serving as noteworthy concern against various diseases that are related to GNB, it further stimulates growth avenues in the market.
Increased number of R & D activities along with rising investments for technological advancements are predicted to boost growth opportunities in the market.
Increased requirement for effective healthcare solutions owing to rising infections among people from developing countries is predicted to attract trends in the market.
Reduced awareness about technological advancements in industry solutions among people from developing nations is expected to limit growth avenues in the market.